Sascha G.
- Country
- Germany
- Department
- 40249: Dermatologie/Allergologie
Research Overview
- A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study)
- Efficacy and Safety of Lebrikizumab in Adults With Nummular Dermatitis Inadequately Controlled by Topical Corticosteroids: A Phase 3, Randomized, Placebo-Controlled Study
- A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of NAV-240 in Adults with Moderate-to-Severe Hidradenitis Suppurativa
Data & Insights
Has run more than one trial at 377 of 668 partner sites.
Specializations
Inflammatory Skin Conditions
The investigator specializes in treating various forms of atopic dermatitis and plaque psoriasis, with particular focus on moderate to severe manifestations in both adult and pediatric populations.
- Moderate to severe atopic dermatitis management
- Pediatric and adult plaque psoriasis treatment
- Long-term disease control strategies
Rare Dermatological Disorders
Expertise extends to treating complex dermatological conditions including hidradenitis suppurativa, bullous pemphigoid, and cutaneous lupus erythematosus.
- Chronic skin inflammation management
- Autoimmune skin disorder treatment
- Novel therapeutic approaches
Specialized Dermatological Conditions
The investigator addresses specific dermatological challenges including prurigo nodularis, lichen simplex chronicus, and weight-dependent therapeutic considerations in skin disorders.
- Chronic pruritus management
- Neurodermatitis treatment
- Body weight-adjusted therapy approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.